|Referral date||01 July 2009|
|Closing date for invited submissions / evidence submission:||TBC|
|1st appraisal committee meeting:||TBC|
|6 April 2011||
The Department of Health has asked us to carry out a single technology appraisal of everolimus within its licensed indication for the prevention of organ rejection in cardiac transplantation.
Following on from information received from the manufacturer, dates for this appraisal will be confirmed once regulatory approval timelines are established.
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance